A coup for stroke treatment as Perfuze raises €3m seed funding
Company: Perfuze
Done Deal:€3m funding
The clincher:“Perfuze has a technology with the potential to significantly improve outcomes for stroke patients” - John Yianni, Earlybird
Perfuze, the medtech start-up developing neuro-vascular technology to treat strokes, has raised €3 million in a seed funding round led by European VC Earlybird.
Established last April by co-founders Wayne Allen and Liam Mullins, Perfuze is developing catheter-based technology to treat acute ischemic stroke.
Ischemic stroke is caused by ...